Key executive orders impacting operations at HHS health agencies

Biopharma execs weigh in on Trump tariffs

Trump tariffs trigger US capital commitments

Dec. 8

Ireland plots to safeguard US investment in biomanufacturing sector

Dec. 4

ACIP votes on changes to hep B immunization delayed once again 

Dec. 3

Data-based concerns reveal consequence of hep B backsliding

Dec. 2

UK/US deal fixes import tariff on drugs at 0% for next 3 years

More uncertainty at FDA as Pazdur plans to resign

Last-minute changes made ahead of ACIP meeting 

Dec. 1

US vaccine path under (re)construction

Nov. 21

RFK skirts promise as CDC alters vaccine-autism webpage

Nov. 19

Partisan rhetoric heats up in Rx price-lowering jousting

Nov. 17. 2025

Scrutiny of NIH funding cuts, potential retaliation continues

Nov. 13, 2025

Makary, Prasad suggest more spokes for bespoke pathway

Nov. 12, 2025

Could restricting diversity efforts stall women’s health research?

Nov. 11, 2025

Trump’s MFN price deals a wake-up call for governments in Europe

Nov. 10, 2025

FDA easing warning on HRTs to boost women’s long-term health

Nov. 6, 2025

Lilly, Novo MFN deals expected to ‘democratize’ obesity drugs

Oct. 30

US, South Korea trade deal eases industry’s pharma tariff fears

Oct. 21

Trade associations push back on Trump Section 232 review

Oct. 15

White House ushering in new era of EO governance?

BIX 2025: What ‘radical’ changes in US, China mean for bio sector 

Oct. 13

Rx tariff a stick and a carrot for US price, onshoring deals

Oct. 6

Latest ACIP recommendations added to CDC vaccine schedules

Oct. 2

So far, ACIP vaccine recommendations in line with the world

Sept. 30

HHS rolls the numbers as shutdown looms for US government

Pfizer inks first pricing deal under Trump MFN plan

Sept. 26

Trump hits drug imports with 100% tariffs, starting Oct. 1

MFN pricing model under White House review 

Sept. 25

US expands tariff investigations into medtech, robotics, diagnostics

More US federal layoffs, future of SBIR on the table

Sept. 23

New FDA fast track for repurposed drugs?

Biotech leaders: Macroeconomics, US policy shifts making M&A harder

Sept. 19

Decide on COVID-19 shot at your own peril: ACIP

Sept. 18

Pediatrics group absent from US CDC vaccine discussion

ACIP delays vote on hep B vaccine, proposal not as bad as feared

Sept. 17

Cancer vaccines face collateral damage of mRNA funding cuts

ACIP meeting cause for consternation at US Senate hearing

Monarez gives her side of how she was fired from the CDC

Sept. 16

Animosity toward mRNA COVID vaccines puts basic science at risk

Advisory committee meetings becoming a rarity at the FDA?

Halt of biopharma investment prompts emergency UK hearing

Sept. 15

The domino effect of cutting mRNA vaccine research

Sept. 12

US chaos positions China as more dependable leader 

Sept. 10

US FDA cracking down on prescription drug ads

Sept. 9

Kennedy: All US vaccines to be reviewed

Sept. 4

US senators call for Kennedy’s resignation in health care hearing

Sept. 3

OBBBA changes odds for next round of US Rx price negotiations

Kennedy critic axed from FDA vaccine adcom

Aug. 29

Aging researchers see no cause for joy as O’Neill helms CDC

Aug. 28

Monarez out at CDC as FDA restricts new COVID vaccines

Aug. 25

Medtech Europe wary of US, EU trade deal’s exclusion of devices

Aug. 22

Stopgaps help some survive, but over time, NIH funding is unique

Aug. 21

EU, US lock in 15% max Rx tariff, no relief for medtech

Aug. 14

US API stockpile added to onshoring toolbox

Aug. 11

Trump EO to change the landscape of US grants, awards

A mild market reaction for companies on Prasad’s return

Aug. 7

US FDA looking to help with Rx moving woes ahead of tariff

Aug. 6

US HHS cancels 22 BARDA mRNA vaccine contracts

HHS appoints acting general counsel as FDA chief counsel

Aug. 4

Not much of a wait for the other ACIP shoe drop 

Aug. 1

Industry looking to adapt under shadow of US Rx tariffs

July 31

Adopt MFN pricing or else, drug companies told 

NIH to receive a $400M boost under Senate spending bill 

July 30

CBER departure spurs Street celebration, ACIP investigation looms

July 28

EU president: 15% tariffs ‘a clear ceiling’ for pharma exports to US

Republican senators flag NIH funding delays

July 23

Ridding US vaccines of thimerosal prioritized over RSV prep

July 16

Rx tariffs a few weeks away?

July 9

Optimism prevails despite talk of 200% biopharma tariff

HELP sends CDC nominee on her way to Senate vote

July 7

Massive budget reconciliation bill restores deductibility of R&D expenses

Court order holds HHS to the law when removing online data

US medical groups challenge Kennedy’s COVID-19 changes 

July 3

Kennedy adopts two ACIP vaccine recommendations 

June 26

ACIP delivers good news for Merck, makes unprecedented precedent

June 25

No vote, ACIP recurring theme at CDC confirmation hearing

June 24

HHS budget hearing mashup of the worst and the best

No postponement likely for ACIP meeting

June 23

Under new management, ACIP faces intense scrutiny

June 20

CBER shakeup points to further FDA realignment 

June 18

BIO 2025: Makary lays out FDA’s path, launches pilot review program

US universities developing alternative to cover indirect costs

June 17

Too much at stake for dismissed ACIP members to go quietly

June 16

Federal judge reinstates funding for NIH DEI grants

June 12

New ACIP members to review data for current vaccine schedules

June 10

Vaccines meeting to go on in wake of ACIP demolition

June 2

White House budget proposal would cut FDA, slash NIH budgets

May 29

US trade court blocks emergency tariffs, but threat remains

HHS terminating Moderna’s $590M grant for flu vaccines

May 27

Kennedy welcomes end of COVID-19 vaccines for healthy kids 

May 22

White House eyes 11% cut in FDA budget authority for 2026

May 20

US HHS calls for MFN pricing commitments

US FDA rethinks COVID-19 boosters

May 15

US threat of most-favored-nation Rx pricing intensifies

May 14

Kennedy on HELP hot seat over budget, cuts and layoffs

May 13

Korea pharma stocks rally; Celltrion welcomes US drug pricing

HHS asks for input on which regs to kill 

May 12

Pause on tariffs could boost med-tech earnings

Most-favored nation Rx pricing voluntary, for now

With trade agreement secured, US and UK await section 232 outcome

May 9

Investors unfazed by uncertainties around tariffs in med tech

Navigating the Trump tariffs, part two: Amgen, Biogen, others

May 8

US legal issues to track in pharma, biotech: Bio Korea 2025

May 7

Some unshod by Prasad nod as CBER change socks stocks

South Korea urges US to exempt pharma, allies from tariffs

US-funded gain-of-function research paused for stiffer oversight

May 6

EO offers US onshoring relief, FDA steps up foreign inspections

US states seek to undo HHS reorg, terminations

More stringency expected under new CBER head

May 5

Annual US 301 trade report has louder bark

Med-tech financings and guidance strong despite tariffs

May 2

Navigating the Trump tariffs: Biopharma execs weigh in

May 1

Klobuchar reiterates opposition to Trump tariffs

Filling the NIH funding gap to protect biopharma research

‘Everything is possible’: Pharmas navigate US market uncertainties

US HHS touts NIH-developed universal vaccine platform

April 30

Emerging markets presents opportunities for med tech

Senate hearing: US biomedical research at a crossroads

April 29

EO record among Day 100 Trump achievements

Advamed, Medtech Europe sound off on tariffs

April 28

100 days of uncertainty

April 25

Vaccine Integrity Project launched to tackle ‘unfortunate reality’

Med tech majors unfazed by tariffs

April 24

Boston Sci expects $200M tariff hit, still raises guidance

Clarification: Nonvoting industry adcom members still possible

US capital crunch pushes China biotechs to roundabout financings

April 23

US HHS axes women’s health research

Chinabio 2025: Europe-China pharma deals rise as US markets shut

Free trade zones not a simple workaround for tariffs

MDMA’s Leahey skeptical of reports of the demise of user fees

April 22

Roche follows other pharmas, committing $50B in US investment

Harvard fighting back with lawsuit against Trump administration

The BioWorld Insider podcast: Bracing for the impact of tariffs and grant cuts

• Listen to the full podcast

April 21

Makary’s vision for slimmed-down US FDA somewhat reassuring

April 18

Budget woes ahead for US life sciences sector?

Ouch! Tariffs hit med tech harder than expected

April 17

Ouch! Tariffs hit med tech harder than expected

April 16

New Trump order zeroes in on drug prices

April 15

Impact of tariffs on supplies of semiconductor tough to calculate

April 14

Biopharma tariffs becoming more than a threat

April 11

Novartis boosting US manufacturing with $23B investment

April 10

Dems petition White House to ensure drug supply chains stay intact

Loss of experience at US FDA raises concerns as impact felt

April 9

Many US tariffs paused, pharma warned, EU put on notice

US-China trade war accelerates with biotech in the crosshairs

April 8

Experts cite deadly consequences of PEPFAR funding disruption

Markets lose ground as US Senate meets on Trump tariffs

Europe’s med-tech companies assessing implications of tariffs

Many med-tech company supply chains protected from tariffs

April 7

US court says no to NIH indirect rate cut, another suit filed

April 3

Impact of Trump tariffs on med tech proving difficult to anticipate

Biopharma exempt from US reciprocal tariffs, but not untouched

Tariffs pressure industry markets; uncertainty remains

Asia in firing line of Trump tariffs, but health care escapes largely unscathed

With ‘wholesale assault’ on research, bipartisan alarm at institutional failure

April 2

Trump cuts are 'gutting' research grants, 'destabilizing' science

US to impose ‘kind reciprocal’ tariffs on country-by-country basis

Kennedy called to Senate HELP hearing on HHS reorg

April 1

Where’s the ‘radical transparency’ Kennedy promised?

March 31

Marks’ departure intensifies regulatory uncertainty at US FDA

March 28

Australia looks to Asia as Trump administration threatens funding

Medidata CEO says digital therapeutics, drugs future of patient treatment

March 27

BIO survey points to ‘damaging impacts’ of Trump tariffs

HHS to cut staffing levels by 20,000 under efficiency initiative

March 26

Senate votes in Makary, Bhattacharya at FDA and NIH

March 25

Oz hits Wyden’s wall of skepticism in Senate CMS post hearing

March 24

CDC’s ACIP meeting rescheduled

March 21

EU seeking talented scientists amid US funding woes

March 19

Trump halves the FTC, firing Democratic commissioners

March 18

WHO looking to fill funding gap left by the US

March 14

Oz promises AI, innovation, lower drug prices if confirmed to lead CMS

Lost in trans-lation? Trump’s mouse charge doesn’t click

March 13

US CDC nomination withdrawn, reforms in the works

Just one more vote to go for FDA, NIH nominees

March 10  

As tariffs threaten US imports of APIs, companies reshore manufacturing

CDC briefing: Trump cuts disrupt disease surveillance, deplete talent

March 6  

US FDA nominee HELPed on the way to confirmation

March 5  

Bhattacharya shares his vision for US NIH

March 4  

Trump’s EOs keep coming as US agencies await new leadership

March 3  

NIH changes set industry up for workforce, ideas drought

Pallone, DeGette push back on FDA, other HHS dismissals

Feb, 25  

New admin toes the Biden line on Rx price negotiations

Feb. 24  

US lawmakers tell Kennedy: No more ‘indiscriminate’ terminations

Feb. 21  

Amid the chaos, focus on innovation, says Stifel’s Opler

Raft of FDA job cuts may slow med-tech approvals

Feb. 20  

Still waiting for the dust to settle at US FDA, throughout HHS

Feb. 19  

Pharmaceuticals named as tariff target, starting at 25%

Feb. 18  

Thousands of US HHS staff terminated in name of efficiency

AAAS 2025: Former NIH head Bertagnolli sounds warning on funding cuts

Feb. 14  

Trump administration an existential threat to science, warns AAAS chief

Feb. 13  

NIH funding plans threaten to derail ‘synergistic partnership’

Uncertainty builds amid Kennedy confirmation, Trump’s orders

Feb. 11

Court orders full stop to US NIH slashing of indirect rates

Infographic: Indirect costs of NIH grants

BIO CEO 2025: Navigating from policy to innovation to patients

BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812

Feb. 10  

BIO CEO 2025: A ‘nice upswing’ in VC rounds, but uncertainty looms

Scientists warn NIH cost-cutting will impair research

Feb. 7  

Trump’s executive orders stacking up, along with challenges

Trump administration presents a mixed picture for med tech

Admin's actions toward science agencies 'not a measured reappraisal'

Mixed reactions from Asia on biotech implications of Trump 2.0

Speculations rise on US tariff impact on global pharma industry

Feb. 5

Doctors group sues US CDC, FDA, HHS over data takedown

Feb. 4

Kennedy advances toward confirmation as HHS secretary

China blacklists Illumina as part of US tariffs counter

Feb. 3

Trump’s new tariffs likely to hit med tech, but impact uncertain

One vote could keep RFK from getting out of committee

Jan. 29

Confirmation hearings begin for RFK as US HHS secretary

The science on vaccines and autism: no there there

FDA diversity-in-trials rules evaporate after ‘strident’ Trump EO

Jan. 23

Mum’s the word at US health agencies awaiting new leadership

Jan. 14

European Commission pushes back on Beijing’s med-tech policy